SG Americas Securities’s Definium Therapeutics DFTX Stock Holding History

SG Americas Securities’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	28,262 +17,769	+169%	+$439K	﹤0.01%	1706
2026 Q1	$198K	Buy	+10,493	New	+$178K	﹤0.01%	2645
2025 Q1	–	Sell	-24,406	Closed	-$170K	–	3635
2024 Q4	$170K	Buy	24,406 +8,004	+49%	+$55.1K	﹤0.01%	2306
2024 Q3	$93K	Buy	+16,402	New	+$114K	﹤0.01%	3100
2022 Q1	–	Sell	-4,143	Closed	-$86K	–	3270
2021 Q4	$86K	Sell	4,143 -5,259	-56%	-$168K	﹤0.01%	3116
2021 Q3	$329K	Buy	9,402 +8,232	+704%	+$356K	﹤0.01%	2859
2021 Q2	$61K	Buy	+1,170	New	+$61.4K	﹤0.01%	2723

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SG Americas Securities's DFTX Position: Q2 2026 in Review

SG Americas Securities increased its Definium Therapeutics (DFTX) stake by 169% in Q2 2026, buying an estimated $439K and bringing the position to 28,262 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

SG Americas Securities first reported a position in DFTX in Q2 2021 and has held it in 7 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

SG Americas Securities held 28,262 shares of Definium Therapeutics worth $1.33M as of Q2 2026.
SG Americas Securities bought 17,769 Definium Therapeutics shares in Q2 2026, an estimated $439K.
Definium Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1706 holding.
SG Americas Securities first reported a position in Definium Therapeutics in Q2 2021 and has held it in 7 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.